Publikace
- Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group2013 | Publikace bez příslušnosti k fakultě
- Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study2024 | 2. lékařská fakulta
- Vliv chemoterapeutické léčby na kognitivní funkce dětí s leukemií2023 | 1. lékařská fakulta, 2. lékařská fakulta
- Doporučení České hematologické společnosti pro diagnostiku a léčbu imunitní trombocytopenie dospělých2023 | Ústřední knihovna
- Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia2022 | Publikace bez příslušnosti k fakultě
- Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study2022 | Publikace bez příslušnosti k fakultě
- Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach2022 | Publikace bez příslušnosti k fakultě
- Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS2022 | Publikace bez příslušnosti k fakultě
- A distinct CD38+CD45RA+ population of CD4+, CD8+, and double-negative T cells is controlled by FAS2021 | 2. lékařská fakulta
- Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data2021 | 2. lékařská fakulta
Loading network view...